Recombinant zoster vaccine uptake and series completion among immunocompromised adults with cancer in the US
{{output}}
Purpose: To estimate recombinant zoster vaccine (RZV) use among adults with cancer since the 2021 US Advisory Committee on Immunization Practices (ACIP) recommendation to vaccinate immunocompromised adults aged ≥ 19 years and ga... ...
